| Target Price | HK$3.47 |
| Price | HK$3.28 |
| Potential |
5.73%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target China Resources Medical 2026 .
The average China Resources Medical target price is HK$3.47.
This is
5.73%
register free of charge
HK$5.25
60.06%
register free of charge
HK$3.03
7.62%
register free of charge
|
|
| A rating was issued by 11 analysts: 1 Analysts recommend China Resources Medical to buy, 2 to hold and 8 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the China Resources Medical stock has an average upside potential 2026 of
5.73%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 10.91 | 10.84 |
| 2.50% | 0.66% | |
| EBITDA Margin | 15.05% | 14.93% |
| 6.87% | 0.79% | |
| Net Margin | 5.74% | 5.71% |
| 125.23% | 0.56% |
5 Analysts have issued a sales forecast China Resources Medical 2025 . The average China Resources Medical sales estimate is
This results in the following potential growth metrics:
5 China Resources Medical Analysts have issued a net profit forecast 2025. The average China Resources Medical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 0.50 | 0.48 |
| 117.39% | 4.00% | |
| P/E | 6.88 | |
| EV/Sales | 0.42 |
5 Analysts have issued a China Resources Medical forecast for earnings per share. The average China Resources Medical EPS is
This results in the following potential growth metrics and future valuations:
China Resources Medical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


